Malaysian Genomics to market 'GenomeCheck' testing services in SEA


KUALA LUMPUR: Malaysian Genomics Resources Centre Bhd has entered into a distribution agreement with South Korea's Dx&Vx Co Ltd in a collaboration to ensure the smooth market entry of GenomeCheck, the latter company's genome testing services, in Southeast Asia.

In a filing with Bursa Malaysia, MGRC said it will be responsible for transporting the collected specimens to the designated testing locations using appropriate methods.

It will also be responsible for the development and expansion of the market through vigorous promotional and sales activities.

DxVx, meanwhile, will commit to providing the necessary promotional and academic materials to support

MGRCT advertising and sales activities.

The agreement shall be valid from June 28, 2024, until June 27, 2025, which unless terminated by either party, will be automatically extended for another year.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

MGRC , genomics , Dx&Vx , GenomeCheck

   

Next In Business News

FBM KLCI slides at midday as market sentiment remains cautious
Indonesia's November exports up 9.1% y/y, more than expected
Sime Darby Property retains AA+IS rating for RM4.5bil sukuk for fourth year
China's factory output up, but consumption still a drag
Malaysia’s capital market hits RM4 trillion milestone, driven by strong domestic growth and IPO surge
TopVision makes ACE Market debut with 18% premium
China November industrial output rises 5.4%, above expectations
Foreign investors extend Bursa Malaysia sell-off with RM882.4mil outflow
Bitcoin surges above US$106,000 on strategic reserve hopes
Ringgit up marginally against US dollar in early trade

Others Also Read